Targeting of syndecan-1 by microRNA miR-10b promotes breast cancer cell motility and invasiveness via a Rho-GTPase- and E-cadherin-dependent mechanism

Syndecan-1 in Breast Cancer Stroma Fibroblasts Regulates Extracellular Matrix Fiber Organization and Carcinoma Cell Motility

(2011) Ning Yang et al.   AMERICAN JOURNAL OF PATHOLOGY

MicroRNA-10b induces glioma cell invasion by modulating MMP-14 and uPAR expression via HOXD10

(2011) Lihua Sun et al.   BRAIN RESEARCH

Heparin Impairs Angiogenesis through Inhibition of MicroRNA-10b

(2011) Xiaokun Shen et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Syndecan-1 antigen, a promising new target for triple-negative breast cancer immuno-PET and radioimmunotherapy. A preclinical study on MDA-MB-468 xenograft tumors

(2011) Caroline Rousseau et al.   EJNMMI Research

Therapeutic silencing of miR-10b inhibits metastasis in a mouse mammary tumor model

(2010) Li Ma et al.   NATURE BIOTECHNOLOGY

miR-145-dependent targeting of Junctional Adhesion Molecule A and modulation of fascin expression are associated with reduced breast cancer cell motility and invasiveness

(2010) M Götte et al.   ONCOGENE

Comprehensive modeling of microRNA targets predicts functional non-conserved and non-canonical sites

(2010) Doron Betel et al.   GENOME BIOLOGY

Rho signaling, ROCK and mDia1, in transformation, metastasis and invasion

(2009) Shuh Narumiya et al.   CANCER AND METASTASIS REVIEWS

Loss of RhoB Expression Promotes Migration and Invasion of Human Bronchial Cells Via Activation of AKT1

(2009) E. Bousquet et al.   CANCER RESEARCH

Differential roles for membrane-bound and soluble syndecan-1 (CD138) in breast cancer progression

(2009) Viktoriya Nikolova et al.   CARCINOGENESIS

Stromal Matrix Protein Expression Following Preoperative Systemic Therapy in Breast Cancer

(2009) A.-M. Tokes et al.   CLINICAL CANCER RESEARCH

Syndecan-1 regulates αvβ3and αvβ5integrin activation during angiogenesis and is blocked by synstatin, a novel peptide inhibitor

(2009) DeannaLee M. Beauvais et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Role of the Heparan Sulfate Proteoglycan Syndecan-1 (CD138) in Delayed-Type Hypersensitivity

(2009) B. K. Masouleh et al.   JOURNAL OF IMMUNOLOGY

MicroRNA expression profiling of human metastatic cancers identifies cancer gene targets

(2009) Raffaele Baffa et al.   JOURNAL OF PATHOLOGY

Targeting RhoA/Rho Kinase and p21-Activated Kinase Signaling to Prevent Cancer Development and Progression

(2009) Yu-Wen Chang et al.   Recent Patents on Anti-Cancer Drug Discovery

Prognostic impact of syndecan-1 expression in invasive ductal breast carcinomas

(2008) D Loussouarn et al.   BRITISH JOURNAL OF CANCER

Reactive glia are recruited by highly proliferative brain metastases of breast cancer and promote tumor cell colonization

(2008) Daniel P. Fitzgerald et al.   CLINICAL & EXPERIMENTAL METASTASIS

Transcriptional upregulation of p21/WAF/Cip1 in myeloid leukemic blasts expressing AML1-ETO

(2008) T. Berg et al.   HAEMATOLOGICA

Role of Rho GTPases in breast cancer

(2007) Yong Tang   Frontiers in Bioscience-Landmark